Home / Adalimumab / Belgium
BE ATC L04AB04 · updated 2 Nov 2026
Adalimumab shortage in Belgium
Is there an Adalimumab shortage in Belgium?
Yes. As of 2 Nov 2026, 3 Adalimumab products are reported short in Belgium, the first since 11 Mar 2026. The company estimate for the return is 31 Dec 2026. Main reason: other.
Also short in United States, Germany, Italy, Spain, Austria, Czechia, Sweden. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Yuflyma 40 mg (PI Pharma) inj. sol. s.c. pre-filled pen 6 x 0.4 ml | Celltrion Healthcare Hungary | 11 Mar 2026 | 31 Dec 2026 | Other Other reason |
| BE | Hukyndra 40 mg (Orifarm) inj. sol. s.c. pre-filled pen 2 x 0.4 ml | Stada Arzneimittel | 10 Jul 2026 | 31 Dec 2026 | Other Other reason |
| BE | Hukyndra 40 mg (Orifarm) inj. sol. s.c. pre-filled pen 6 x 0.4 ml | Stada Arzneimittel | 10 Jul 2026 | 31 Dec 2026 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.